From Target Discovery to Precision Medicine

The Finnish Biobank Cooperative – FINBB and Fingenious® will organize the “From Target Discovery to Precision Medicine – the Unique Potential of Finnish Biobanks in Biomedical Research” symposium on the 30th of September. It will bring together professionals from pharma, biotech, and academia from all over the world and offers a spectrum of real-life cases in neurology, immunology, oncology, ophthalmology, and rare diseases. 

With examples spanning from target discovery to personalized medicine in action, cases presented by international-level experts elucidate the research opportunities that Finnish biobanks and the unique genetic heritage of Finns offer.